Manipulation of the immune system by non-small cell lung cancer and possible therapeutic interference.

Cancer Drug Resist · 2020 · PMC8992558 · PMID 35582213

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Several in-vivo approaches demonstrated a highly significant clinical benefit under dual blockade of PDL1 and LAG3, whereas the efficacy was very low in cases of single agent targeting [ 51 ] .

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.